US Stock MarketDetailed Quotes

INCY Incyte

Watchlist

51.740
+0.090+0.17%

Close Apr 24 16:00 ET

51.700
-0.040-0.08%

Post 18:00 ET

11.62BMarket Cap19.52P/E (TTM)

Incyte Stock Forum

Moomoo AI

Feb 28 01:21

Significant insider selling at Incyte and lack of purchases over the last year may suggest insiders don't view shares as a bargain. The history of sales makes us cautious about the stock.

Possible Bearish Signals With Incyte Insiders Disposing Stock

Moomoo AI

Feb 1 19:06

Despite a recent earnings dip, Incyte's high P/E ratio indicates investor anticipation of strong future growth. This is expected to continue bolstering the share price unless earnings significantly deteriorate.

Investors Interested In Incyte Corporation's (NASDAQ:INCY) Earnings

Moomoo AI

Dec 10, 2023 20:28

Incyte's seemingly unimpressive ROE contradicts its strong net income growth and high reinvestment rate, indicating a healthier financial condition. Future earnings growth, hinging on efficient profit reinvestment, is expected to sustain.

Incyte Corporation (NASDAQ:INCY) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Moomoo AI

Nov 6, 2023 22:21

The relevance of a major insider selling at a high price may be limited to the stock's current position. With limited insider ownership, Incyte illustrates only a moderate alignment with other shareholders. Promising signs would include future substantial insider purchases.

68% Of This Incyte Insider's Holdings Were Sold

Moomoo AI

Oct 7, 2023 22:19

Despite Incyte becoming profitable with steady revenue growth, its consistent share price drop could concern investors. Consider analyst consensus estimates and Incyte's 2 warning signs before making investment decisions.

The Past Three Years for Incyte (NASDAQ:INCY) Investors Has Not Been Profitable

GAME_DAY

Aug 3, 2023 04:39

Daily alerts recap 🔥

$PayPal(PYPL.US)$$Wynn Resorts(WYNN.US)$$Molson Coors Beverage(TAP.US)$$Incyte(INCY.US)$$Yellow(YELL.US)$$Forte Biosciences(FBRX.US)$$Applied Therapeutics(APLT.US)$$Adamis Pharmaceuticals(ADMP.US)$

GAME_DAY

Aug 3, 2023 01:54

Current watch ⚡️

$Molson Coors Beverage(TAP.US)$$Incyte(INCY.US)$$PayPal(PYPL.US)$$Advanced Micro Devices(AMD.US)$$Match group(MTCH.US)$$Applied Therapeutics(APLT.US)$$T Stamp(IDAI.US)$$Aurora Acquisition Corp(AURC.US)$$Yellow(YELL.US)$$Vertex Pharmaceuticals(VRTX.US)$

Movers and Shakers

Aug 1, 2023 20:27

ColumnsToday's Pre-Market Stock Movers And Top Ratings: GAP, UBER, SOFI, EL and More

Pre-Market Stock Movers
Gapping up
$Gap Inc(GPS.US)$
(The retail stock climbed nearly 4% after Barclays upgraded Gap to overweight from equal weight. Analyst Adrienne Yih assigned a $13 price target to the company, which suggests shares could rally 26.2% from Monday's close. )
$Incyte(INCY.US)$
(Shares rose 2% after Incyte beat analysts' expectations in its latest results. The pharmaceutical company reported second-q...

Alvinnnnnnngenius

Jun 23, 2023 11:12

I expect this to hit 52 high week soon insider keep loading

$Incyte(INCY.US)$

Analysts Notebook

May 4, 2023 20:04

ColumnsUS Top Rating Updates on 5/4: PACW, INCY, QRVO, NBIX and More

Citigroup Downgrades Wingstop to Neutral, Raises Price Target to $224
Citigroup analyst Jon Tower downgrades $Wingstop(WING.US)$ from Buy to Neutral and raises the price target from $204 to $224.
ZoomInfo Technologies Initiated at Buy by DA Davidson
$ZoomInfo(ZI.US)$ Price Target Announced at $30.00/Share by DA Davidson.
PacWest Downgraded to Neutral From Buy by DA Davidson
$PacWest Bancorp(PACW.US)$ Downgraded to Neutral From Buy, Sto...

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall